# William H. Yong

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/william-h-yong/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,233 |
| Field | Glioma Diagnosis and Treatment |
| h-index | 68 |
| i10-index | 162 |
| Last Known Institution | University of California, Irvine |
| OpenAlex ID | https://openalex.org/A5016190247 |
| Works | 438 |

## Researcher papers

- [Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma](https://scholariq.org/papers/neoadjuvant-anti-pd-1-immunotherapy-promotes-a-survival-benefit-with/)
- [Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme](https://scholariq.org/papers/phase-ii-study-of-bevacizumab-plus-temozolomide-during-and-after-radiation/)
- [Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin](https://scholariq.org/papers/evidence-for-sequenced-molecular-evolution-of-i-idh1-i-mutant-glioblastoma-from/)
- [Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors](https://scholariq.org/papers/differential-sensitivity-of-glioma-versus-lung-cancer-specific-egfr-mutations-to/)

## Researcher topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [University of California, Irvine](https://scholariq.org/institutions/university-of-california-irvine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.